Future Science Group announces special rheumatology publication

Future Science Group has published a mini focus issue of its Future Medicinal Chemistry journal, detailing new developments in the field of rheumatology.

The special issue is accessible online and features contributions from academic experts based in Europe, North America and Asia, including various comprehensive reviews and opinion pieces.

Subjects covered include the implications of targeting visfatin and sphingosine kinases in rheumatoid arthritis, potential uses of cannabinoids and the possible risks of targeting proteins and pathways that are involved both in rheumatic disease progression and resolution.

This comes at a time when medicinal chemistry in the rheumatology field is progressing at a rapid pace, with a growing number of small and large molecules being developed as therapeutic candidates.

Contributing author Robert Scheinman of the University of Colorado said: "This issue focuses both on a look back at established therapies and their limitations and a look forward on new targets and their potentials for developing new therapeutics."

Last month, the publisher produced a special focus issue of its Pharmacogenomics journal, highlighting innovative new breast cancer research.